Stock listing
Cordlife Group Limited
Selected listing: P8A · SGX · SGD · SG
Cordlife Group Limited (SGX:P8A), Health Services. Latest release May 13, 2026: Cordlife : Reports Improved Operational Performance In 1Q2026 Despite Lower…
- Ticker
- SGX:P8A
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- SGX
- Currency
- SGD
About Cordlife Group Limited
Cordlife Group Limited, trading under the ticker P8A, is a public company listed on the Singapore market. Cordlife specializes in cord blood and tissue banking services, providing parents with options for preserving their newborn's stem cells.
Latest news from Cordlife Group Limited
Cordlife : Reports Improved Operational Performance In 1Q2026 Despite Lower Revenue
May 13, 2026
Cordlife : Records FY2025 Revenue Of $38.9 Million; Uncompromising Commitment On Safety, Quality And Compliance
February 27, 2026
Cordlife : Reports 9M2025 Revenue Of S$29.4 Million; Focuses On Regulatory Compliance And Operational Recovery
November 16, 2025
Cordlife : Extension of Time granted by MOH to provide Written Representations
October 12, 2025
Cordlife : Update on Going Concern Assessment
October 5, 2025
Research Cordlife Group Limited
Cordlife Group Limited company profile
View the public company page for Cordlife Group Limited on 6ix.
Cordlife Group Limited news
Read company news and market updates connected to Cordlife Group Limited.
Cordlife Group Limited investor events
Find investor webinars, events, and replay context for Cordlife Group Limited.